Targeting Glycogen Metabolism as a Novel Therapeutic Approach in Anaplastic Thyroid Cancer

por Davidson, Cole, Tomczak, Jennifer, Amiel, Eyal, Carr, Frances
Publicado 2021

SAT-571 Restoration of Thyroid Hormone Receptor Beta Signaling Reprograms Anaplastic Thyroid Cancer Cells

por Gillis, Noelle, Bolf, Eric, Davidson, Cole, Tomczak, Jennifer, Frietze, Seth, Carr, Frances
Publicado 2019

Thyroid hormone dependent transcriptional programming by TRβ requires SWI/SNF chromatin remodelers

por Gillis, Noelle E, Boyd, Joseph R, Tomczak, Jennifer A, Frietze, Seth, Carr, Frances E
Publicado 2022

SAT-573 Characterization of the Gene Expression Program of a Mutant Thyroid Hormone Receptor in Anaplastic Thyroid Cancer

por Bolf, Eric, Gillis, Noelle, Tomczak, Jennifer, Stein, Janet, Stein, Gary, Lian, Jane, Frietze, Seth, Carr, Frances
Publicado 2019

Thyroid Hormone Receptor Beta Inhibits PI3K-Akt-mTOR Signaling Axis in Anaplastic Thyroid Cancer via Genomic Mechanisms

por Davidson, Cole D, Bolf, Eric L, Gillis, Noelle E, Cozzens, Lauren M, Tomczak, Jennifer A, Carr, Frances E
Publicado 2021

OR21-03 Determining Novel Therapeutic Targets Using an in Vitro Model of TRb Tumor Suppression in Anaplastic Thyroid Cancer

por Gillis, Noelle E, Bolf, Eric L, Davidson, Cole, Cozzens, Lauren, Tomczak, Jennifer, Lian, Jane B, Frietze, Seth, Carr, Frances E
Publicado 2020

Tumor-associated mutations in a conserved structural motif alter physical and biochemical properties of human RAD51 recombinase

por Chen, Jianhong, Morrical, Milagros D., Donigan, Katherine A., Weidhaas, Joanne B., Sweasy, Joann B., Averill, April M., Tomczak, Jennifer A., Morrical, Scott W.
Publicado 2015